Simon Mooijaart
@drsimonpm.bsky.social
Professor of #Medicine and #Geriatrics
🏡 Lives: Leiderdorp, NL
🏥 Works: Leiden University Medical Center, Leiden, NL
🤩 Likes: 🚴🏻 #cycling, 📸 #photography, 🎶 #music
Mostly English 🇺🇸 / Sometimes Dutch 🇳🇱
Views my own
🏡 Lives: Leiderdorp, NL
🏥 Works: Leiden University Medical Center, Leiden, NL
🤩 Likes: 🚴🏻 #cycling, 📸 #photography, 🎶 #music
Mostly English 🇺🇸 / Sometimes Dutch 🇳🇱
Views my own
OpenAI is exploring “consumer health tools”.
If an AI is giving health advice, that’s medicine at scale.
And if it’s medicine, three things are non-negotiable:
1️⃣ Doctors in the loop
2️⃣ Older people in the design – not as an afterthought
3️⃣ Data that actually contains older people
buff.ly/h4bkdCJ
If an AI is giving health advice, that’s medicine at scale.
And if it’s medicine, three things are non-negotiable:
1️⃣ Doctors in the loop
2️⃣ Older people in the design – not as an afterthought
3️⃣ Data that actually contains older people
buff.ly/h4bkdCJ
November 18, 2025 at 8:13 AM
OpenAI is exploring “consumer health tools”.
If an AI is giving health advice, that’s medicine at scale.
And if it’s medicine, three things are non-negotiable:
1️⃣ Doctors in the loop
2️⃣ Older people in the design – not as an afterthought
3️⃣ Data that actually contains older people
buff.ly/h4bkdCJ
If an AI is giving health advice, that’s medicine at scale.
And if it’s medicine, three things are non-negotiable:
1️⃣ Doctors in the loop
2️⃣ Older people in the design – not as an afterthought
3️⃣ Data that actually contains older people
buff.ly/h4bkdCJ
The system isn’t broken. It’s obsolete.
We’re not overwhelmed by ageing.
We’re paying the price for decades of lazy design.
The healthcare system was never built for older people.
It was built for short-term fixes, single diseases, and people who recover fast.
buff.ly/gpXtDpR
We’re not overwhelmed by ageing.
We’re paying the price for decades of lazy design.
The healthcare system was never built for older people.
It was built for short-term fixes, single diseases, and people who recover fast.
buff.ly/gpXtDpR
Nearly 150,000 aged 90 and above wait 12 hours in England’s A&Es each year
Older people left in their own excrement and wet beds for hours and forced to watch others die, Age UK report finds
buff.ly
November 15, 2025 at 4:26 PM
The system isn’t broken. It’s obsolete.
We’re not overwhelmed by ageing.
We’re paying the price for decades of lazy design.
The healthcare system was never built for older people.
It was built for short-term fixes, single diseases, and people who recover fast.
buff.ly/gpXtDpR
We’re not overwhelmed by ageing.
We’re paying the price for decades of lazy design.
The healthcare system was never built for older people.
It was built for short-term fixes, single diseases, and people who recover fast.
buff.ly/gpXtDpR
If you read (social) media about AI, you almost become afraid of what AI will do to healthcare.
Personally, I’m more afraid of what will become of care without AI.
Despite the hype, the mistakes, the hallucinations, the threats I believe AI can make care better.
❓ What do you think?
#AI #MedSky
Personally, I’m more afraid of what will become of care without AI.
Despite the hype, the mistakes, the hallucinations, the threats I believe AI can make care better.
❓ What do you think?
#AI #MedSky
October 25, 2025 at 7:12 PM
People aged over‑70 spend more time online than 40‑somethings.
“Is that going to work for older people? Can they even use it?
Reality: yes they can!
Read further: buff.ly/UJ3Bw8N
#AI #medsky #geriatrics
buff.ly/WtykNYL
“Is that going to work for older people? Can they even use it?
Reality: yes they can!
Read further: buff.ly/UJ3Bw8N
#AI #medsky #geriatrics
buff.ly/WtykNYL
October 19, 2025 at 7:30 PM
People aged over‑70 spend more time online than 40‑somethings.
“Is that going to work for older people? Can they even use it?
Reality: yes they can!
Read further: buff.ly/UJ3Bw8N
#AI #medsky #geriatrics
buff.ly/WtykNYL
“Is that going to work for older people? Can they even use it?
Reality: yes they can!
Read further: buff.ly/UJ3Bw8N
#AI #medsky #geriatrics
buff.ly/WtykNYL
“Who am I to stop taking my medication?"
Patient Perspectives on Antithrombotic Therapy in Advanced Cancer
#cancer #thrombosis #geriatrics #medsky #medication #sdm #palliative
oncodaily.com/voices/simon...
Patient Perspectives on Antithrombotic Therapy in Advanced Cancer
#cancer #thrombosis #geriatrics #medsky #medication #sdm #palliative
oncodaily.com/voices/simon...
Simon Mooijaart: Patient Perspectives on Antithrombotic Therapy in Advanced Cancer - OncoDaily
Simon Mooijaart: Patient Perspectives on Antithrombotic Therapy in Advanced Cancer / Anette Arbjerg Højen, antithrombotic therapy, cancer, Carme Font, Elin
oncodaily.com
August 26, 2025 at 6:56 AM
“Who am I to stop taking my medication?"
Patient Perspectives on Antithrombotic Therapy in Advanced Cancer
#cancer #thrombosis #geriatrics #medsky #medication #sdm #palliative
oncodaily.com/voices/simon...
Patient Perspectives on Antithrombotic Therapy in Advanced Cancer
#cancer #thrombosis #geriatrics #medsky #medication #sdm #palliative
oncodaily.com/voices/simon...
🧠 "#AI not one-size-fits-all”?
It’s not even one thing!
#AI is many has many faces:
🧮 Predictive models: Structured data — labs, claims, vitals — outcomes, stratify risk,.
🗣️ NLP, LLMs, and Generative AI: Messy, human language — summarize, interpret, engage
Read more on LinkedIn: buff.ly/mbYjbxB
It’s not even one thing!
#AI is many has many faces:
🧮 Predictive models: Structured data — labs, claims, vitals — outcomes, stratify risk,.
🗣️ NLP, LLMs, and Generative AI: Messy, human language — summarize, interpret, engage
Read more on LinkedIn: buff.ly/mbYjbxB
buff.ly
August 25, 2025 at 9:08 AM
🧠 "#AI not one-size-fits-all”?
It’s not even one thing!
#AI is many has many faces:
🧮 Predictive models: Structured data — labs, claims, vitals — outcomes, stratify risk,.
🗣️ NLP, LLMs, and Generative AI: Messy, human language — summarize, interpret, engage
Read more on LinkedIn: buff.ly/mbYjbxB
It’s not even one thing!
#AI is many has many faces:
🧮 Predictive models: Structured data — labs, claims, vitals — outcomes, stratify risk,.
🗣️ NLP, LLMs, and Generative AI: Messy, human language — summarize, interpret, engage
Read more on LinkedIn: buff.ly/mbYjbxB
“𝗪𝗵𝗼 𝗮𝗺 𝗜 𝘁𝗼 𝘀𝘁𝗼𝗽 𝘁𝗮𝗸𝗶𝗻𝗴 𝗺𝘆 𝗺𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻?” - 𝘢 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘢𝘴𝘬𝘦𝘥 𝘪𝘯 𝘰𝘶𝘳 𝘳𝘦𝘤𝘦𝘯𝘵 𝘴𝘵𝘶𝘥𝘺.
That question stayed with me.
When doctors want to stop medication, wefocus on the clinical reasoning: Risk of bleeding. Limited benefit. A burden.
✔️ All true — but not enough.
Read more on LinkedIn
buff.ly/QxOg1f5
That question stayed with me.
When doctors want to stop medication, wefocus on the clinical reasoning: Risk of bleeding. Limited benefit. A burden.
✔️ All true — but not enough.
Read more on LinkedIn
buff.ly/QxOg1f5
August 24, 2025 at 3:26 PM
“𝗪𝗵𝗼 𝗮𝗺 𝗜 𝘁𝗼 𝘀𝘁𝗼𝗽 𝘁𝗮𝗸𝗶𝗻𝗴 𝗺𝘆 𝗺𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻?” - 𝘢 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘢𝘴𝘬𝘦𝘥 𝘪𝘯 𝘰𝘶𝘳 𝘳𝘦𝘤𝘦𝘯𝘵 𝘴𝘵𝘶𝘥𝘺.
That question stayed with me.
When doctors want to stop medication, wefocus on the clinical reasoning: Risk of bleeding. Limited benefit. A burden.
✔️ All true — but not enough.
Read more on LinkedIn
buff.ly/QxOg1f5
That question stayed with me.
When doctors want to stop medication, wefocus on the clinical reasoning: Risk of bleeding. Limited benefit. A burden.
✔️ All true — but not enough.
Read more on LinkedIn
buff.ly/QxOg1f5
❓ 𝐓𝐡𝐞 𝐦𝐨𝐬𝐭 𝐩𝐨𝐰𝐞𝐫𝐟𝐮𝐥 𝐭𝐨𝐨𝐥 𝐢𝐧 𝐦𝐲 𝐜𝐚𝐫𝐞 𝐟𝐨𝐫 𝐨𝐥𝐝𝐞𝐫 𝐩𝐞𝐨𝐩𝐥𝐞? 𝐋𝐢𝐬𝐭𝐞𝐧𝐢𝐧𝐠!
➡️ 𝐀𝐧𝐝 𝐭𝐡𝐚𝐭 𝐢𝐬 𝐞𝐱𝐚𝐜𝐭𝐥𝐲 𝐰𝐡𝐲 𝐈 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐩𝐫𝐨𝐦𝐢𝐬𝐞 𝐨𝐟 𝐀𝐈 𝐢𝐧
#Geriatrics
Reed more on LinkedIn
www.linkedin.com/feed/update/...
#medmastodon #ai #chatbot
➡️ 𝐀𝐧𝐝 𝐭𝐡𝐚𝐭 𝐢𝐬 𝐞𝐱𝐚𝐜𝐭𝐥𝐲 𝐰𝐡𝐲 𝐈 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐩𝐫𝐨𝐦𝐢𝐬𝐞 𝐨𝐟 𝐀𝐈 𝐢𝐧
#Geriatrics
Reed more on LinkedIn
www.linkedin.com/feed/update/...
#medmastodon #ai #chatbot
August 21, 2025 at 6:55 AM
❓ 𝐓𝐡𝐞 𝐦𝐨𝐬𝐭 𝐩𝐨𝐰𝐞𝐫𝐟𝐮𝐥 𝐭𝐨𝐨𝐥 𝐢𝐧 𝐦𝐲 𝐜𝐚𝐫𝐞 𝐟𝐨𝐫 𝐨𝐥𝐝𝐞𝐫 𝐩𝐞𝐨𝐩𝐥𝐞? 𝐋𝐢𝐬𝐭𝐞𝐧𝐢𝐧𝐠!
➡️ 𝐀𝐧𝐝 𝐭𝐡𝐚𝐭 𝐢𝐬 𝐞𝐱𝐚𝐜𝐭𝐥𝐲 𝐰𝐡𝐲 𝐈 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐩𝐫𝐨𝐦𝐢𝐬𝐞 𝐨𝐟 𝐀𝐈 𝐢𝐧
#Geriatrics
Reed more on LinkedIn
www.linkedin.com/feed/update/...
#medmastodon #ai #chatbot
➡️ 𝐀𝐧𝐝 𝐭𝐡𝐚𝐭 𝐢𝐬 𝐞𝐱𝐚𝐜𝐭𝐥𝐲 𝐰𝐡𝐲 𝐈 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐩𝐫𝐨𝐦𝐢𝐬𝐞 𝐨𝐟 𝐀𝐈 𝐢𝐧
#Geriatrics
Reed more on LinkedIn
www.linkedin.com/feed/update/...
#medmastodon #ai #chatbot
Help, my AI has a delirium 😵💫
Last week - as a test - I asked an AI "who is Simon Mooijaart?" It gave me a confident, detailed answer... about someone else entirely 🙃
As a geriatrician, this instantly reminded me of delirium - a condition I see daily at the bedside: #delirium
🧵 1/8
Last week - as a test - I asked an AI "who is Simon Mooijaart?" It gave me a confident, detailed answer... about someone else entirely 🙃
As a geriatrician, this instantly reminded me of delirium - a condition I see daily at the bedside: #delirium
🧵 1/8
August 15, 2025 at 7:06 PM
Help, my AI has a delirium 😵💫
Last week - as a test - I asked an AI "who is Simon Mooijaart?" It gave me a confident, detailed answer... about someone else entirely 🙃
As a geriatrician, this instantly reminded me of delirium - a condition I see daily at the bedside: #delirium
🧵 1/8
Last week - as a test - I asked an AI "who is Simon Mooijaart?" It gave me a confident, detailed answer... about someone else entirely 🙃
As a geriatrician, this instantly reminded me of delirium - a condition I see daily at the bedside: #delirium
🧵 1/8
Reposted by Simon Mooijaart
Well said. Not including older adults in research studies about diseases that primarily affect older adults is just ageism, pure and simple.
slate.com/technology/2...
slate.com/technology/2...
The Most Common Kind of Cancer Patient in America Is the One We Study the Least
At 82, would former President Joe Biden even qualify for the trials he funded?
slate.com
May 21, 2025 at 3:42 AM
Well said. Not including older adults in research studies about diseases that primarily affect older adults is just ageism, pure and simple.
slate.com/technology/2...
slate.com/technology/2...
Reposted by Simon Mooijaart
Incredible evening launching @acha020.bsky.social having a peek into the amazing research and community work for the population of East London planned with the fabulous @proflizsampson.bsky.social & @adamgordon1978.bsky.social
April 30, 2025 at 6:08 PM
Incredible evening launching @acha020.bsky.social having a peek into the amazing research and community work for the population of East London planned with the fabulous @proflizsampson.bsky.social & @adamgordon1978.bsky.social
Reposted by Simon Mooijaart
April 27, 2025 at 8:33 PM
Reposted by Simon Mooijaart
☑️ The original CAM does work when used by trained raters
‼️ But an unvalidated CAM variant - with no cognitive testing/interview - is widely used in clinical practice
⚠️ This 'CAM-Lite' has dangerously low sensitivity
➡️ New blog on this critical issue in #delirium care
Link below⏬
‼️ But an unvalidated CAM variant - with no cognitive testing/interview - is widely used in clinical practice
⚠️ This 'CAM-Lite' has dangerously low sensitivity
➡️ New blog on this critical issue in #delirium care
Link below⏬
April 27, 2025 at 8:32 PM
☑️ The original CAM does work when used by trained raters
‼️ But an unvalidated CAM variant - with no cognitive testing/interview - is widely used in clinical practice
⚠️ This 'CAM-Lite' has dangerously low sensitivity
➡️ New blog on this critical issue in #delirium care
Link below⏬
‼️ But an unvalidated CAM variant - with no cognitive testing/interview - is widely used in clinical practice
⚠️ This 'CAM-Lite' has dangerously low sensitivity
➡️ New blog on this critical issue in #delirium care
Link below⏬
🥳 Superproud of this bunch: the management team of the CoClarity #RCT. Submitted the trial protocol today.
#CoClarity: A Shared Decision Support Tool to reconsider the use of Anti-Thrombotic Therapy in patients with #cancer in the last phase of life:
✅ Lower risk of #thrombosis
🛑 Risk of bleeding
#CoClarity: A Shared Decision Support Tool to reconsider the use of Anti-Thrombotic Therapy in patients with #cancer in the last phase of life:
✅ Lower risk of #thrombosis
🛑 Risk of bleeding
April 25, 2025 at 7:07 PM
🥳 Superproud of this bunch: the management team of the CoClarity #RCT. Submitted the trial protocol today.
#CoClarity: A Shared Decision Support Tool to reconsider the use of Anti-Thrombotic Therapy in patients with #cancer in the last phase of life:
✅ Lower risk of #thrombosis
🛑 Risk of bleeding
#CoClarity: A Shared Decision Support Tool to reconsider the use of Anti-Thrombotic Therapy in patients with #cancer in the last phase of life:
✅ Lower risk of #thrombosis
🛑 Risk of bleeding
Very nice #thesis defense by Jonathan Bogaerts earlie this week. 🧑🏻🎓
Depresribing of antihypertensive medication in the very old, an inspiring topic for lively (and funny) discussion!
🥳 Congratulations, Jonathan!
#geriatrics #hypertension #medsky
Depresribing of antihypertensive medication in the very old, an inspiring topic for lively (and funny) discussion!
🥳 Congratulations, Jonathan!
#geriatrics #hypertension #medsky
April 19, 2025 at 9:08 AM
Very nice #thesis defense by Jonathan Bogaerts earlie this week. 🧑🏻🎓
Depresribing of antihypertensive medication in the very old, an inspiring topic for lively (and funny) discussion!
🥳 Congratulations, Jonathan!
#geriatrics #hypertension #medsky
Depresribing of antihypertensive medication in the very old, an inspiring topic for lively (and funny) discussion!
🥳 Congratulations, Jonathan!
#geriatrics #hypertension #medsky
Reposted by Simon Mooijaart
The latest in our @acha020.bsky.social blog series - Shared Opportunities and Challenges - ACHA forges a research collaboration with the LUMC Centre for Medicine for Older People.
@wilcoachterberg.bsky.social @drsimonpm.bsky.social @proflizsampson.bsky.social
acha.qmul.ac.uk/research/sha...
@wilcoachterberg.bsky.social @drsimonpm.bsky.social @proflizsampson.bsky.social
acha.qmul.ac.uk/research/sha...
Shared Opportunities and Challenges – ACHA forges a research collaboration with the LUMC Centre for Medicine for Older People - Academic Centre for Healthy Ageing
acha.qmul.ac.uk
April 9, 2025 at 11:31 AM
The latest in our @acha020.bsky.social blog series - Shared Opportunities and Challenges - ACHA forges a research collaboration with the LUMC Centre for Medicine for Older People.
@wilcoachterberg.bsky.social @drsimonpm.bsky.social @proflizsampson.bsky.social
acha.qmul.ac.uk/research/sha...
@wilcoachterberg.bsky.social @drsimonpm.bsky.social @proflizsampson.bsky.social
acha.qmul.ac.uk/research/sha...
Use of #AI decreases with increasing age.
✅ #AI offers a lot of promises also in care for older people
❌ #AI is not tailored to needs of older people
➡️ We have work to do
🔗 JAMA, buff.ly/2jxuUhz
#geriatrics #digital #medsky
✅ #AI offers a lot of promises also in care for older people
❌ #AI is not tailored to needs of older people
➡️ We have work to do
🔗 JAMA, buff.ly/2jxuUhz
#geriatrics #digital #medsky
March 24, 2025 at 8:56 AM
Use of #AI decreases with increasing age.
✅ #AI offers a lot of promises also in care for older people
❌ #AI is not tailored to needs of older people
➡️ We have work to do
🔗 JAMA, buff.ly/2jxuUhz
#geriatrics #digital #medsky
✅ #AI offers a lot of promises also in care for older people
❌ #AI is not tailored to needs of older people
➡️ We have work to do
🔗 JAMA, buff.ly/2jxuUhz
#geriatrics #digital #medsky
Very nice #thesis by Jonathan Bogaerts:
📓 High blood pressure and its treatment in the very old - balancing benefits and risks
🧑🎓 Defense April 16th at #Leiden University
😀 really looking forward
#geriatrics #hypertension #medsky
📓 High blood pressure and its treatment in the very old - balancing benefits and risks
🧑🎓 Defense April 16th at #Leiden University
😀 really looking forward
#geriatrics #hypertension #medsky
March 21, 2025 at 10:21 AM
Very nice #thesis by Jonathan Bogaerts:
📓 High blood pressure and its treatment in the very old - balancing benefits and risks
🧑🎓 Defense April 16th at #Leiden University
😀 really looking forward
#geriatrics #hypertension #medsky
📓 High blood pressure and its treatment in the very old - balancing benefits and risks
🧑🎓 Defense April 16th at #Leiden University
😀 really looking forward
#geriatrics #hypertension #medsky
Nice presentation by #PhD candidate Denise Abbel about the complex choice to use #antithrombotic therapy in patients with #cancer in the last phase of life:
✅ prevention of thrombic events
❌ risk of bleeding
❓what is more important?
#oncology #geriatrics
✅ prevention of thrombic events
❌ risk of bleeding
❓what is more important?
#oncology #geriatrics
February 20, 2025 at 1:21 PM
Nice presentation by #PhD candidate Denise Abbel about the complex choice to use #antithrombotic therapy in patients with #cancer in the last phase of life:
✅ prevention of thrombic events
❌ risk of bleeding
❓what is more important?
#oncology #geriatrics
✅ prevention of thrombic events
❌ risk of bleeding
❓what is more important?
#oncology #geriatrics
Nice hike 🥾 exploring the surroundings of the Symposium 😀
January 26, 2025 at 4:22 PM
Nice hike 🥾 exploring the surroundings of the Symposium 😀
Signing in at the European #Pancreas Islet Transplantation Association Symposium for a talk tomorrow on #transplantation in older people
📍Igls, Innsbruck, #Austria
#geriatrics
📍Igls, Innsbruck, #Austria
#geriatrics
January 26, 2025 at 4:20 PM
Signing in at the European #Pancreas Islet Transplantation Association Symposium for a talk tomorrow on #transplantation in older people
📍Igls, Innsbruck, #Austria
#geriatrics
📍Igls, Innsbruck, #Austria
#geriatrics
🥳 Kudos to Eva Kempers!
📝 Our study in #Thrombosis and #Haemostasis explores anticoagulant use in life-limiting diseases
➡️ most patients continued until end-of-life with comparable risks of bleeding or clots after stopping
🔗 10.1055/a-2524-5334
#palliativecare #geriatrics
📝 Our study in #Thrombosis and #Haemostasis explores anticoagulant use in life-limiting diseases
➡️ most patients continued until end-of-life with comparable risks of bleeding or clots after stopping
🔗 10.1055/a-2524-5334
#palliativecare #geriatrics
January 26, 2025 at 11:38 AM
🥳 Kudos to Eva Kempers!
📝 Our study in #Thrombosis and #Haemostasis explores anticoagulant use in life-limiting diseases
➡️ most patients continued until end-of-life with comparable risks of bleeding or clots after stopping
🔗 10.1055/a-2524-5334
#palliativecare #geriatrics
📝 Our study in #Thrombosis and #Haemostasis explores anticoagulant use in life-limiting diseases
➡️ most patients continued until end-of-life with comparable risks of bleeding or clots after stopping
🔗 10.1055/a-2524-5334
#palliativecare #geriatrics
Reposted by Simon Mooijaart
🚨 Excited to share our work : "Systemic treatment among frail older patients with cancer".
✅ 3-month OS 81.8% when guided by geriatric assessments.
⚠️ Loss of ADL and cumulative frailty factors associated with poorer survival
🔗https://www.geriatriconcology.net/article/S1879-4068(24)00450-8/abstract
✅ 3-month OS 81.8% when guided by geriatric assessments.
⚠️ Loss of ADL and cumulative frailty factors associated with poorer survival
🔗https://www.geriatriconcology.net/article/S1879-4068(24)00450-8/abstract
Systemic treatment among frail older patients with cancer: An observational cohort
In the past, certain oncological therapies were not offered to frail older patients. However, the advancement of geriatric oncology, tailored chemotherapy regimens, the introduction of new treatments, and the optimization of supportive care have contributed to enhancing the therapeutic margin. We aimed to evaluate the benefit of systemic treatment among older adults by assessing the three-month survival of older frail patients with metastatic cancer.
www.geriatriconcology.net
December 30, 2024 at 9:40 AM
🚨 Excited to share our work : "Systemic treatment among frail older patients with cancer".
✅ 3-month OS 81.8% when guided by geriatric assessments.
⚠️ Loss of ADL and cumulative frailty factors associated with poorer survival
🔗https://www.geriatriconcology.net/article/S1879-4068(24)00450-8/abstract
✅ 3-month OS 81.8% when guided by geriatric assessments.
⚠️ Loss of ADL and cumulative frailty factors associated with poorer survival
🔗https://www.geriatriconcology.net/article/S1879-4068(24)00450-8/abstract
Reposted by Simon Mooijaart
Artificial intelligence (AI) in health care has seen remarkable growth.
What is the potential of AI to improve care management, clinical decision-making efficiency, and more?
📑 Read this Review in The Lancet Digital Health: bit.ly/3DwAJtD
What is the potential of AI to improve care management, clinical decision-making efficiency, and more?
📑 Read this Review in The Lancet Digital Health: bit.ly/3DwAJtD
December 28, 2024 at 4:52 PM
Artificial intelligence (AI) in health care has seen remarkable growth.
What is the potential of AI to improve care management, clinical decision-making efficiency, and more?
📑 Read this Review in The Lancet Digital Health: bit.ly/3DwAJtD
What is the potential of AI to improve care management, clinical decision-making efficiency, and more?
📑 Read this Review in The Lancet Digital Health: bit.ly/3DwAJtD
Reposted by Simon Mooijaart
On "Face Age"
>300,000 people have taken Novos free #AI test
(a company that sells longevity kits & supplements) without published data
wsj.com/health/welln...
"People who use face-age tests to estimate their biological age should take the results with a grain of salt"
@andrewlbeam.bsky.social
>300,000 people have taken Novos free #AI test
(a company that sells longevity kits & supplements) without published data
wsj.com/health/welln...
"People who use face-age tests to estimate their biological age should take the results with a grain of salt"
@andrewlbeam.bsky.social
December 28, 2024 at 7:18 PM
On "Face Age"
>300,000 people have taken Novos free #AI test
(a company that sells longevity kits & supplements) without published data
wsj.com/health/welln...
"People who use face-age tests to estimate their biological age should take the results with a grain of salt"
@andrewlbeam.bsky.social
>300,000 people have taken Novos free #AI test
(a company that sells longevity kits & supplements) without published data
wsj.com/health/welln...
"People who use face-age tests to estimate their biological age should take the results with a grain of salt"
@andrewlbeam.bsky.social